Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederesmo.org
ESMO News
Get the latest updates from ESMO News directly as they happen.
Follow now 78 followers
Latest posts
Last updated 19 minutes ago
Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC
19 minutes ago
Findings from the third pre-specified interim analysis of the OlympiA study
New Translations of the ESMO Patient Guides Available in Estonian
3 days ago
Translations in the Estonian Language of the Patient Guides on Bone Health...
EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide
3 days ago
It was intended for PET imaging of somatostatin receptor overexpression in adult...
Aiming to Support Cancer Research, ESMO Calls on the European Council to Allocate a Budget of at Least €220 to Horizon Europe
3 days ago
Financing pan-European cancer research projects under Horizon Europe and the EU’s Multiannual...
Trend in Survival Benefit with a Combination of Spartalizumab Plus Dabrafenib and Trametinib Over Targeted Therapy Alone for BRAF V600-mutated Metastatic Melanoma
4 days ago
Findings from the COMBI-I study
FDA Approves Pembrolizumab or Pembrolizumab and Berahyaluronidase alfa-pmph Each with Enfortumab Vedotin-ejfv for Muscle Invasive Bladder Cancer
5 days ago
Evidence for efficacy is based on the results from the KEYNOTE-B15/EV-304 study
Thymus Radiation is Linked to Worse Outcomes in Patients with Non-Small Cell Lung Cancer
5 days ago
Until recently, the thymus was thought to be of little use beyond...
Metastatic Breast Cancer: ESMO Living Guideline
7 days ago
Prepared by E de Azambuja and N Harbeck, the ESMO Metastatic Breast...
No Additional Benefit From Tiragolumab Plus Atezolizumab Over Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation
7 days ago
Findings from the SKYSCRAPER-03 study
EMA Recommends Extension of Indications for Datopotamab Deruxtecan
10 days ago
New indication concerns the first-line treatment of adult patients with unresectable or...
High-Dose Chemotherapy Followed by ASCT Improves Survival Compared with Non-myeloablative Consolidation in Primary CNS Lymphoma
11 days ago
Findings from the MATRix/IELSG43 study
Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years for Patients with Metastatic Hormone-Sensitive Prostate Cancer
12 days ago
Findings from the ENZAMET (ANZUP 1304) study